| RS1554049422 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS1554049816 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS1554049825 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS1554049882 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS1554050112 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS1554050230 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation syndrome |
| RS1554050342 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1554050517 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554050584 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS1554050960 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554051033 |
PIK3R1
|
Health Risk |
Pathogenic |
Immunodeficiency 36 with lymphoproliferation, Immunodeficiency 36 with lymphoproliferation |
| RS1554051067 |
PIK3R1
|
Health Risk |
Pathogenic |
Immunodeficiency 36 with lymphoproliferation, Immunodeficiency 36 with lymphoproliferation |
| RS1554051075 |
PIK3R1
|
Health Risk |
Pathogenic |
Immunodeficiency 36 with lymphoproliferation, SHORT syndrome |
| RS1554051094 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS1554051161 |
PIK3R1
|
Health Risk |
Likely pathogenic |
— |
| RS1554051268 |
PIK3R1
|
Health Risk |
Likely pathogenic |
— |
| RS1554053289 |
NEK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1554054155 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1554054827 |
MAP1B
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia, Periventricular nodular heterotopia |
| RS1554054831 |
MAP1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Periventricular nodular heterotopia, Periventricular nodular heterotopia 9 |
| RS1554054880 |
MAP1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Periventricular nodular heterotopia, Periventricular nodular heterotopia 9 |
| RS1554055106 |
MAP1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular nodular heterotopia, Periventricular nodular heterotopia 9 |
| RS1554058577 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554059248 |
NDUFS4
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1554059320 |
RICTOR
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554059454 |
BLTP1
|
Health Risk |
Pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS1554059509 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554059550 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554059573 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554059974 |
MAB21L2
|
Health Risk |
Likely pathogenic |
— |
| RS1554060168 |
NDUFS4
|
Health Risk |
Likely pathogenic |
— |
| RS1554062097 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554062168 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554062343 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554062352 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554062427 |
NDUFS4
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1554062562 |
TRIO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1554062588 |
TRIO
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554062741 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554062789 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554062804 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554062814 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554063600 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554063656 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554063934 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1554064083 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Lung cancer |
| RS1554064102 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS1554064175 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554064737 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1554064740 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS1554064863 |
TRIO
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554064929 |
TLR3
|
Health Risk |
risk factor |
Immunodeficiency 83, susceptibility to viral infections |
| RS1554065254 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554065670 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554065671 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554065887 |
TRIO
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Inborn genetic diseases |
| RS1554065893 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1554066045 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Endometrial carcinoma, Endometrial carcinoma |
| RS1554066077 |
DHFR;MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554066080 |
DHFR;MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1554066397 |
SMN1
|
Health Risk |
Likely pathogenic |
Spinal muscular atrophy, type II |
| RS1554066421 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554066659 |
SMN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kugelberg-Welander disease, Kugelberg-Welander disease |
| RS1554066666 |
SMN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinal muscular atrophy, type II |
| RS1554066684 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1554067009 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554067104 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554067106 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1554067124 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554067141 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554067157 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554067164 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554067166 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554067182 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1554068134 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554068136 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554068272 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554068426 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1554068529 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS1554068790 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS1554068885 |
ADGRV1
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1554068960 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554069481 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554069524 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554069549 |
APC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Familial adenomatous polyposis 1 |
| RS1554069570 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1554069573 |
APC
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS1554069592 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554069610 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1554069655 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069660 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069661 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069668 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069669 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069710 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Neoplasm |
| RS1554069775 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069786 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069791 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069793 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554069805 |
APC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |